We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Generic Drug Co. Can Continue Arbitration Against Ranbaxy

Law360 (March 13, 2018, 7:13 PM EDT) -- A Texas appellate court on Monday allowed a generic drug developer to move forward in arbitration with claims it had been fraudulently induced to assign patent rights to Ranbaxy Inc., reversing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.